$IPCI Headlines Strong Demand For Resistance Tec
Post# of 102800
Posted On: 01/08/2014 10:41:30 AM
$IPCI Headlines
Strong Demand For Resistance Technology Bodes Well For IntelliPharmaCeutics 12:06 p.m. Dec. 17, 2013 - Seeking Alpha
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 4:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Strength Seen in IntelliPharmaCeutics (IPCI): Stock Shoots 161.9% - Tale of the Tape 9:04 a.m. Nov. 20, 2013 - Zacks.com
Small Cap Stocks: Why IPCI Stock Went Bonkers 2:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Alcatel-Lucent Left in the Lurch by Nokia and 2 More Heavily Traded Stocks to Follow 4:14 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Intellipharmaceutics still Buy-rated following Focalin XR generic news 10:05 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics nearly doubles on generic Focalin XR approval 8:31 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics Reports Loss - Analyst Blog 1:15 p.m. Oct. 7, 2013 - Zacks.com
IntelliPharmaCeutics Sell Off On Acura Data Overdone... Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics Sell Off On ACUR Data Overdone... Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IPCI Sell Off On ACUR Data Overdone...Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics - Primed For An Easy Double 5:07 a.m. Aug. 22, 2013 - Seeking Alpha
Intellipharmaceutics Announces Pricing of Public Offering of 1.5 Million Common Shares and Warrants 7:31 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Files Shelf Registration 3:55 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Up on Positive Data - Analyst Blog 4:40 p.m. July 22, 2013 - Zacks.com
Intellipharmaceutics: A Bio-Better Generics Play On The Cutting Edge 9:19 a.m. July 17, 2013 - Seeking Alpha
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 5:04 a.m. July 15, 2013 - benzinga.com
4 Drug Delivery Companies That Deliver For Investors 4:21 p.m. Feb. 27, 2013 - Seeking Alpha
Small Pharma Watch List: Week Of January 21st 12:16 p.m. Jan. 22, 2013 - Seeking Alpha
3 Dirt Cheap Drug Companies About To Make A Comeback 3:16 a.m. Nov. 6, 2012 - Seeking Alpha
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces At-The-Market Offering of Common Shares 4:30 p.m. Nov. 27, 2013 - GlobeNewswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI 12:17 a.m. Nov. 21, 2013 - ACCESSWIRE
TrendingWallStreet.com Releases Volume Coverage on NCT, VEND, PGLO, and IPCI 12:20 a.m. Nov. 20, 2013 - ACCESSWIRE
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 19, 2013 - ACCESSWIRE
Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) 4:35 p.m. Nov. 18, 2013 - GlobeNewswire
Intellipharmaceutics Announces Third Quarter 2013 Results 4:00 p.m. Oct. 1, 2013 - GlobeNewswire
Intellipharmaceutics Closes Public Offering for US$3.1 Million 4:25 p.m. July 31, 2013 - GlobeNewswire
Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants 8:30 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants 1:07 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 6:00 a.m. July 15, 2013 - GlobeNewswire
Intellipharmaceutics Announces Second Quarter 2013 Results 5:00 p.m. July 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference 4:00 p.m. April 24, 2013 - GlobeNewswire
Intellipharmaceutics Announces First Quarter 2013 Results 4:30 p.m. April 3, 2013 - GlobeNewswire
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units 1:52 p.m. March 25, 2013 - GlobeNewswire
Intellipharmaceutics to Raise US$3.1 Million 8:08 a.m. March 19, 2013 - GlobeNewswire
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R) 5:00 p.m. March 13, 2013 - GlobeNewswire
Intellipharmaceutics Announces 2012 Year End Results 9:52 p.m. Jan. 31, 2013 - GlobeNewswire
Strong Demand For Resistance Technology Bodes Well For IntelliPharmaCeutics 12:06 p.m. Dec. 17, 2013 - Seeking Alpha
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 4:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Strength Seen in IntelliPharmaCeutics (IPCI): Stock Shoots 161.9% - Tale of the Tape 9:04 a.m. Nov. 20, 2013 - Zacks.com
Small Cap Stocks: Why IPCI Stock Went Bonkers 2:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Alcatel-Lucent Left in the Lurch by Nokia and 2 More Heavily Traded Stocks to Follow 4:14 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Intellipharmaceutics still Buy-rated following Focalin XR generic news 10:05 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics nearly doubles on generic Focalin XR approval 8:31 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics Reports Loss - Analyst Blog 1:15 p.m. Oct. 7, 2013 - Zacks.com
IntelliPharmaCeutics Sell Off On Acura Data Overdone... Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics Sell Off On ACUR Data Overdone... Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IPCI Sell Off On ACUR Data Overdone...Compelling Entry Point 6:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics - Primed For An Easy Double 5:07 a.m. Aug. 22, 2013 - Seeking Alpha
Intellipharmaceutics Announces Pricing of Public Offering of 1.5 Million Common Shares and Warrants 7:31 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Files Shelf Registration 3:55 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Up on Positive Data - Analyst Blog 4:40 p.m. July 22, 2013 - Zacks.com
Intellipharmaceutics: A Bio-Better Generics Play On The Cutting Edge 9:19 a.m. July 17, 2013 - Seeking Alpha
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 5:04 a.m. July 15, 2013 - benzinga.com
4 Drug Delivery Companies That Deliver For Investors 4:21 p.m. Feb. 27, 2013 - Seeking Alpha
Small Pharma Watch List: Week Of January 21st 12:16 p.m. Jan. 22, 2013 - Seeking Alpha
3 Dirt Cheap Drug Companies About To Make A Comeback 3:16 a.m. Nov. 6, 2012 - Seeking Alpha
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces At-The-Market Offering of Common Shares 4:30 p.m. Nov. 27, 2013 - GlobeNewswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI 12:17 a.m. Nov. 21, 2013 - ACCESSWIRE
TrendingWallStreet.com Releases Volume Coverage on NCT, VEND, PGLO, and IPCI 12:20 a.m. Nov. 20, 2013 - ACCESSWIRE
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 19, 2013 - ACCESSWIRE
Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) 4:35 p.m. Nov. 18, 2013 - GlobeNewswire
Intellipharmaceutics Announces Third Quarter 2013 Results 4:00 p.m. Oct. 1, 2013 - GlobeNewswire
Intellipharmaceutics Closes Public Offering for US$3.1 Million 4:25 p.m. July 31, 2013 - GlobeNewswire
Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants 8:30 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants 1:07 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 6:00 a.m. July 15, 2013 - GlobeNewswire
Intellipharmaceutics Announces Second Quarter 2013 Results 5:00 p.m. July 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference 4:00 p.m. April 24, 2013 - GlobeNewswire
Intellipharmaceutics Announces First Quarter 2013 Results 4:30 p.m. April 3, 2013 - GlobeNewswire
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units 1:52 p.m. March 25, 2013 - GlobeNewswire
Intellipharmaceutics to Raise US$3.1 Million 8:08 a.m. March 19, 2013 - GlobeNewswire
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R) 5:00 p.m. March 13, 2013 - GlobeNewswire
Intellipharmaceutics Announces 2012 Year End Results 9:52 p.m. Jan. 31, 2013 - GlobeNewswire
(0)
(0)